Request for regulatory safe harbor from AKS for financial support to cancer clinical trial participants

ACS CAN is joined by 21 partner advocacy and professional society partners in requesting a safe harbor from the Anti-Kickback Statute (AKS) for financial support of clinical trial participants. This safe harbor is critical to ensure that clinical trials are representative of the broader population of cancer patients and that low-income or remote patients are not unfairly kept from participation due to financial burdens.  This letter is in response to the annual HHS OIG solicitation of new safe harbors.